These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1725072)

  • 1. Meningococcal molecular mimicry and the search for an ideal vaccine.
    Griffiss JM; Yamasaki R; Estabrook M; Kim JJ
    Trans R Soc Trop Med Hyg; 1991; 85 Suppl 1():32-6. PubMed ID: 1725072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal vaccines--present and future.
    Zollinger WD; Moran E
    Trans R Soc Trop Med Hyg; 1991; 85 Suppl 1():37-43. PubMed ID: 1803695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria lactamica and Neisseria meningitidis share lipooligosaccharide epitopes but lack common capsular and class 1, 2, and 3 protein epitopes.
    Kim JJ; Mandrell RE; Griffiss JM
    Infect Immun; 1989 Feb; 57(2):602-8. PubMed ID: 2463970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune response to anti-meningococcal vaccines].
    Milagres LG; Melles CE
    Rev Saude Publica; 1993 Jun; 27(3):221-6. PubMed ID: 8115838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.
    Braun JM; Beuth J; Blackwell CC; Giersen S; Higgins PG; Tzanakaki G; Unverhau H; Weir DM
    Vaccine; 2004 Feb; 22(7):898-908. PubMed ID: 15040943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease.
    Moe GR; Tan S; Granoff DM
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):209-26. PubMed ID: 10575132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against meningococcal meningitis: current status.
    Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis.
    Troncoso G; Sánchez S; Criado MT; Ferreirós CM
    FEMS Immunol Med Microbiol; 2002 Sep; 34(1):9-15. PubMed ID: 12208601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A].
    Yuan CD
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development.
    Rune Andersen S; Kolberg J; Høiby EA; Namork E; Caugant DA; Oddvar Frøholm L; Jantzen E; Bjune G
    Microb Pathog; 1997 Sep; 23(3):139-55. PubMed ID: 9281472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal vaccines.
    Bethell D; Pollard AJ
    Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.
    Lepow ML; Beeler J; Randolph M; Samuelson JS; Hankins WA
    J Infect Dis; 1986 Dec; 154(6):1033-6. PubMed ID: 3097160
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody studies in mice of outer membrane antigens for use in an improved meningococcal B and C vaccine.
    Milagres LG; Cristina M; Brandileone MC; Sacchi CT; Vieira VS; Zanella RC; Frasch CE
    FEMS Immunol Med Microbiol; 1996 Jan; 13(1):9-17. PubMed ID: 8821393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine for meningococcal meningitis tested.
    Marwick C
    JAMA; 1991 Oct; 266(15):2052-3. PubMed ID: 1920685
    [No Abstract]   [Full Text] [Related]  

  • 18. Right age for Meningococcal vaccine.
    John TJ
    Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antigenic structures, virulence factors, immunity, vaccination and chemoprophylaxis of Meningococci].
    Berkman E
    Mikrobiyol Bul; 1982; 16(4):297-302. PubMed ID: 6820682
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica.
    Kremastinou J; Tzanakaki G; Pagalis A; Theodondou M; Weir DM; Blackwell CC
    FEMS Immunol Med Microbiol; 1999 May; 24(1):73-8. PubMed ID: 10340715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.